Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacillus cereus is a Gram-positive, rod-shaped, spore-forming bacterium found ubiquitously in the environment [1]. It is primarily recognized as a significant cause of food poisoning, manifesting as either an emetic syndrome caused by the heat-stable toxin cereulide or a diarrheal syndrome mediated by heat-labile enterotoxins [1][2]. In addition to gastrointestinal issues, it is an opportunistic pathogen capable of causing severe non-gastrointestinal infections such as endophthalmitis, bacteremia, and meningitis, particularly in neonatal or immunocompromised populations [1][3]. Pharmacologically, B. cereus is notoriously resistant to most beta-lactam antibiotics, including penicillins and cephalosporins, due to the expression of multiple beta-lactamases [3][4]. Effective treatment regimens typically involve the use of vancomycin, clindamycin, or aminoglycosides [1][4]. The ability of the organism to form highly resilient endospores allows it to survive extreme environmental conditions like pasteurization and chemical disinfectants, posing a persistent challenge in both food safety and clinical sterilization protocols [2][5].
Antibiotics targeting Bacillus cereus work through various mechanisms including the inhibition of cell wall synthesis (e.g., Vancomycin), the inhibition of protein synthesis (e.g., Gentamicin, Clindamycin), or the inhibition of DNA gyrase activity (e.g., Ciprofloxacin) [1][4].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacillus cereus (B. cereus).